NCT07006402 Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.
| NCT ID | NCT07006402 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Upper Thoracic Spine Hypomobility |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2024-07-18 |
| Primary Completion | 2025-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2024-07-18 with a primary completion date of 2025-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomized controlled trial and the purpose of the study is to determine the effects of reverse NAGs as compared to Ventro-cranial Translatoric Glides in upper thoracic spine hypomobility in terms of pain and range of motion.
Eligibility Criteria
Inclusion Criteria: * 1\. Both male and females 2. Adults (18-39 years) 3. Upper Thoracic hypomobility (flexion \<20° or extension \<25° or side bending \<20° or rotation \<35°) Exclusion Criteria: * 1-Ankylosing spondylitis 2-History of Spinal Fusion or spinal surgery (discectomy/laminectomy etc.) 3-Degenerative disc disorders 4-Cervical radiculopathy, Scoliosis 5-Spinal Stenosis or Myelopathy 6-Recent fracture or surgery 7-TB of spine, Spondylolisthesis 8-Not able to attend regular therapy appointments 9-Fibromyalgia/myofascial pain syndrome
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07006402 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 39 Years, studying Upper Thoracic Spine Hypomobility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07006402 currently recruiting?
Yes, NCT07006402 is actively recruiting participants. Contact the research team at anamshabbir129@gmail.com for enrollment information.
Where is the NCT07006402 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07006402 clinical trial?
NCT07006402 is sponsored by Foundation University Islamabad. The trial plans to enroll 48 participants.